ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,237.72
-0.42%
Dow Jones
39,150.33
0.04%
Gold vs US Dollar
2,320.79
0.00%
Brent Oil
84.39
0.00%
Bitcoin
64,115.38
-0.20%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Osiris Therape (MM) (OSIR)

  7. Osiris Therape (MM) (OSIR) News

Osiris Therapeutics, Inc. (OSIR)

Osiris Therape (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OSIR
DateTimeSourceHeadlineSymbolCompany
29/04/201921:13Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:OSIROsiris Therape (MM)
17/04/201914:48Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:OSIROsiris Therape (MM)
17/04/201914:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OSIROsiris Therape (MM)
17/04/201914:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OSIROsiris Therape (MM)
17/04/201914:36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OSIROsiris Therape (MM)
17/04/201914:19Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:OSIROsiris Therape (MM)
17/04/201914:18Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:OSIROsiris Therape (MM)
17/04/201914:18Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:OSIROsiris Therape (MM)
17/04/201914:18Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:OSIROsiris Therape (MM)
17/04/201914:18Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:OSIROsiris Therape (MM)
17/04/201914:15Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OSIROsiris Therape (MM)
17/04/201914:05GlobeNewswire Inc.Osiris Therapeutics, Inc. Announces Closing of Acquisition by Smith & Nephew plcNASDAQ:OSIROsiris Therape (MM)
17/04/201911:08Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:OSIROsiris Therape (MM)
17/04/201911:08Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:OSIROsiris Therape (MM)
16/04/201914:02Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:OSIROsiris Therape (MM)
12/04/201913:57Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:OSIROsiris Therape (MM)
10/04/201914:34Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:OSIROsiris Therape (MM)
10/04/201914:30Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:OSIROsiris Therape (MM)
27/03/201921:20Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:OSIROsiris Therape (MM)
27/03/201921:13Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:OSIROsiris Therape (MM)
20/03/201911:43Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:OSIROsiris Therape (MM)
20/03/201911:33Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:OSIROsiris Therape (MM)
15/03/201922:13PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Osiris Therapeutics, Inc.NASDAQ:OSIROsiris Therape (MM)
15/03/201913:03Edgar (US Regulatory)Annual Report (10-k)NASDAQ:OSIROsiris Therape (MM)
12/03/201921:10Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:OSIROsiris Therape (MM)
12/03/201921:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OSIROsiris Therape (MM)
12/03/201921:03Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:OSIROsiris Therape (MM)
12/03/201917:14PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Osiris Therapeutics, Inc.NASDAQ:OSIROsiris Therape (MM)
12/03/201913:33PR Newswire (US)Smith & Nephew expands in high growth regenerative medicine market through acquisition of Osiris Therapeutics, Inc.NASDAQ:OSIROsiris Therape (MM)
12/03/201913:22Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:OSIROsiris Therape (MM)
 Showing the most relevant articles for your search:NASDAQ:OSIR

Your Recent History

NASDAQI
HX10GI
OMX Helsinki Technology GI
NASDAQ
SAAS
COIN
SKELUSD
BITMOT
984986
Belgium Tf 3,45% Gn43 Eur
NASDAQ
FZWKYX
Tax Exempt Municipal Inc...
LSE
56BI
Res.mtg.14 B1aa
LSE
AH50
Xchin Ah50
NASDAQ
OGAR
USOTC
BBAGF
BB Biotech (PK)
USOTC
KKPNF
Koninklijke Kpn Nv (PK)
COIN
CTCNEUR
Creditcoin
LSE
58RU
Newday 26 S
ASX
HSOJOA
NASDAQ
BLBX
BlackBoxStocks
TG
A2R14Y
Coca Cola HBC Finance BV
TG
I10
Italgas
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved